| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/24/2007 | EP1745034A1 Vanilloid receptor ligands and their use in treatments |
| 01/24/2007 | EP1745033A2 4,5-disubstituted-2-aryl pyrimidines |
| 01/24/2007 | EP1745024A1 1-aryl-4-substituted isoquinolines |
| 01/24/2007 | EP1745021A1 Hydroformylation process for pharmaceutical intermediate |
| 01/24/2007 | EP1745019A1 Novel compounds of proline and morpholine derivatives |
| 01/24/2007 | EP1745018A1 Azetidine glycine transporter inhibitors |
| 01/24/2007 | EP1744749A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 01/24/2007 | EP1667992B1 Quinazoline derivatives |
| 01/24/2007 | EP1542986B1 Process for the production of desloratadine |
| 01/24/2007 | EP1507531B1 Stable pharmaceutical compositions of desloratadine |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | EP1363900B1 Isoindole-imide compounds, compositions and uses thereof |
| 01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | CN1902283A Reagent for detecting an analyte |
| 01/24/2007 | CN1902195A Modulators of cellular adhesion |
| 01/24/2007 | CN1902193A Quinoxalines useful as inhibitors of protein kinases |
| 01/24/2007 | CN1902191A Amidopyrazole derivative |
| 01/24/2007 | CN1902190A 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 01/24/2007 | CN1902181A Benzimidazoles useful as modulators of ion channels |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1902172A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1902168A Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 01/24/2007 | CN1902160A Non-symmetrical gelling agent |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1901916A Quinazolinone compounds with reduced bioaccumulation |
| 01/24/2007 | CN1901912A Preparation of pharmaceutical salts of [1, 4] - bipiperidine |
| 01/24/2007 | CN1901910A Substituted piperidines for the treatment of metabolic syndrome |
| 01/24/2007 | CN1900073A Process for preparing N-phenyl-2-pyrimidyl amine derivative |
| 01/24/2007 | CN1900063A Symmetrical diazo compounds, compositions comprising them, method for coloring, and device |
| 01/24/2007 | CN1296369C Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166723 5-hydroxy- or 1-glyceryl-substituted quinolines, isoquinolines or cinnolines as chemical intermediates |
| 01/23/2007 | US7166722 The monohydrochloric acid salt monohydrate, and its preparation by adding hydrochloric acid to a solution of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea in an N,N-dimethylformamide or N,N-dimethylacetamide aprotic solvent, adding ethanol and ethanol and water |
| 01/23/2007 | US7166659 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof |
| 01/23/2007 | US7166635 3-imino-2-indolones for the treatment of depression and/or anxiety |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166628 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1 |
| 01/23/2007 | US7166619 Compounds for treatment of diseases associated with prenylation of proteins |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166615 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166609 Osteoarthritis; periodontal disease; antiarthritic agents |
| 01/23/2007 | US7166607 Substituted indoles |
| 01/23/2007 | US7166606 Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor Xa |
| 01/23/2007 | US7166604 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 01/23/2007 | US7166599 Trisubstituted pyrimidines |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166368 A platinum complexes containing a 2,4-pentanedionate group and pyridyl group, maxima spectral emittance |
| 01/23/2007 | CA2493275C Processes for the preparation of triazinone derivatives |
| 01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
| 01/23/2007 | CA2332188C 5-(1-aminocyclohexyl)-2(1h)-pyridinone compounds and intermediates in the production thereof |
| 01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 01/23/2007 | CA2206754C Benzimidazole derivatives with antihistaminic activity |
| 01/18/2007 | WO2007008895A1 Kinase inhibitors |
| 01/18/2007 | WO2007008501A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/18/2007 | WO2007008146A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008145A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008143A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008142A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008140A1 New pyridine analogues |
| 01/18/2007 | WO2007007890A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007072A1 5-htx modulators |
| 01/18/2007 | WO2007007054A1 Phthalamides, succinimides and related compounds and their use as pharmaceuticals |
| 01/18/2007 | WO2007007041A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007006922A2 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxylase tyrosine inducers |
| 01/18/2007 | WO2007006739A1 Benzoheterocyclylethylcarboxamide derivatives |
| 01/18/2007 | WO2007006688A1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/18/2007 | WO2007006670A1 N-thio-anthranilamid compounds and their use as pesticides |
| 01/18/2007 | WO2007006594A2 Reactive azo dyes, methods for the production thereof and their use |
| 01/18/2007 | WO2007006547A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006546A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006117A1 Novel cyp2a6 inhibitors |
| 01/18/2007 | WO2006128120A3 Novel lapachone compounds and methods of use thereof |
| 01/18/2007 | WO2006127926A3 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
| 01/18/2007 | WO2006117314A3 Novel piperidin- substituted indoles and their use as ccr-3 modulators |
| 01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/18/2007 | WO2006110447A3 Pyrimidine derivatives and their use in the treatment of cancer |
| 01/18/2007 | WO2006083491A3 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 01/18/2007 | WO2006010967A8 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 01/18/2007 | WO2005070893A3 Azadecalin glucocorticoid receptor modulators |
| 01/18/2007 | US20070015794 Endothelial growth factor; angiogenesis inhibitors; antitumor agents; skin disorders; endimetriosis; Crohn's disease; leukemia; antiarthritic agents |
| 01/18/2007 | US20070015788 N-(3-Aryl-3-substitutedphenylpropyl) piperidines or 8-azabicyclo[3.2.1]octanes that are additionally substituted with an optionally fused 5-member N-heterocycle; the compounds are modulators of CCR5 receptor activity and are used in treating diseases such as rheumatoid arthritis |
| 01/18/2007 | US20070015778 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015747 Respiratory syncytial virus replication inhibitors |
| 01/18/2007 | US20070015743 Quinazoline derivatives as antitumor agents |
| 01/18/2007 | DE102005030524A1 Substituierte Chinolone II Substituted Quinolones II |
| 01/18/2007 | CA2615726A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/18/2007 | CA2614726A1 New pyridine analogues |
| 01/18/2007 | CA2614688A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |